What's Happening?
On World Cervical Cancer Elimination Day, the World Health Organization (WHO) is calling for a stronger integration of HIV and cervical cancer services to improve prevention, screening, diagnosis, and treatment for women and girls living with HIV. Women
living with HIV face a six-fold higher risk of developing cervical cancer and often experience poorer outcomes, including a higher mortality rate within 1-2 years of diagnosis and a greater likelihood of residual tumors after radiotherapy. However, when women living with HIV receive antiretroviral therapy (ART) at the start of their cervical cancer treatment, mortality differences become less significant. The WHO's Global Strategy to accelerate the elimination of cervical cancer aims for 90% HPV vaccination coverage among girls by age 15, 70% screening coverage with high-performance tests, and treatment and care for 90% of women identified with cervical cancer and precancerous lesions by 2030.
Why It's Important?
This initiative is crucial for global public health, particularly in regions with high HIV prevalence. By integrating HIV and cervical cancer services, the WHO aims to address health inequities and improve health outcomes for a vulnerable population. The disproportionate burden of cervical cancer on women living with HIV highlights a critical gap in healthcare delivery. Effective integration means leveraging existing HIV programs, which regularly reach women, to also provide HPV screening and treatment for precancerous lesions. This approach can significantly reduce cervical cancer incidence and mortality among women living with HIV, contributing to the overall goal of cervical cancer elimination. It also emphasizes the importance of a person-centered approach to care, ensuring that services are tailored to the specific needs and lived experiences of these women.
What's Next?
The WHO plans to publish a technical policy brief emphasizing the importance of rapid initiation or continuation of ART, multidisciplinary HIV and cancer care, monitoring for treatment toxicity and drug-drug interactions, and support to complete cancer treatment. They are also working with the International Agency for Research on Cancer (IARC) to develop a roadmap for potentially including HPV35 in future HPV vaccines, given its contribution to cervical cancer, especially in the WHO African Region. The focus will be on achieving the 90-70-90 targets of the Global Strategy, ensuring that women at the highest risk, including those living with HIV, are reached. This will involve strengthening existing health systems to provide comprehensive and coordinated care, and advocating for policies that prioritize the needs of women and girls living with HIV.
Beyond the Headlines
The call for integrated services extends beyond medical treatment, touching upon broader issues of health equity and human rights. It underscores the need to dismantle barriers that prevent women living with HIV from accessing timely and effective cancer care. The initiative also highlights the importance of patient advocacy, ensuring that the voices of cervical cancer survivors and women living with HIV are central to shaping their care. This integrated approach could serve as a model for addressing other co-occurring health conditions, promoting a more holistic and equitable healthcare system globally. It also brings to light the ongoing challenges in resource-limited settings, where access to both HIV and cancer diagnosis and treatment remains constrained, emphasizing the need for sustained international support and investment.













